Author:
Torricelli C.,Fortino V.,Capurro E.,Valacchi G.,Pacini A.,Muscettola M.,Soucek K.,Maioli E.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference22 articles.
1. Sustained MAP kinase activation is required for the expression of cyclin-D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells;Balmanno;Oncogene,1999
2. Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase;Cho;Biochimica et Biophysica Acta,2000
3. Regulatory interactions of the calmodulin-binding, inhibitory, and autophosphorylation domains of Ca2+/calmodulin-dependent protein kinase II;Colbran;Journal of Biological Chemistry,1988
4. Specificity and mechanism of action of some commonly used protein kinase inhibitors;Davies;Biochemical Journal,2000
5. Amplification and overexpression of cyclin-D1 in breast cancer detected by immunohistochemical staining;Gillett;Cancer Research,1994
Cited by
40 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献